Showing results (441-450 of 505) with videos related to
Sort By:
Pageof 51
Respiratory Medicine|March 22, 2022
The six-minute walk test in sarcoidosis associated pulmonary hypertension: Results from an international registryRohit Gupta, Robert P Baughman, Steven D Nathan, et al.Nature Medicine|October 6, 2020
Combined PD-1, BRAF and MEK inhibition in advanced BRAF-mutant melanoma: safety run-in and biomarker cohorts of COMBI-iReinhard Dummer, Celeste Lebbé, Victoria Atkinson, et al.The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 1, 2022
Clinical features and allograft failure rates of pulmonary antibody-mediated rejection categoriesAnanth V Charya, Ileana L Ponor, Adam Cochrane, et al.Journal of Pediatric Surgery|October 12, 2018
Update on neuroblastomaErika A Newman, Shahab Abdessalam, Jennifer H Aldrink, et al.The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 21, 2021
Impact of lung morphology on clinical outcomes with riociguat in patients with pulmonary hypertension and idiopathic interstitial pneumonia: A post hoc subgroup analysis of the RISE-IIP studySteven D Nathan, Vincent Cottin, Juergen Behr, et al.Annals of the American Thoracic Society|August 11, 2020
The Pulmonary Fibrosis Foundation Patient Registry. Rationale, Design, and MethodsBonnie R Wang, Rex Edwards, Elizabeth A Freiheit, et al.American Journal of Respiratory and Critical Care Medicine|December 20, 2023
Cell-Free DNA Maps Tissue Injury and Correlates with Disease Severity in Lung Transplant CandidatesShanti Balasubramanian, Mary E Richert, Hyesik Kong, et al.Open Forum Infectious Diseases|April 21, 2025
SARS-CoV-2 Immune Complex-Mediated Neutrophil ActivationKiana C Allen, Seth Warner, Heather L Teague, et al.The Lancet. Oncology|April 22, 2014
Adjuvant bevacizumab in patients with melanoma at high risk of recurrence (AVAST-M): preplanned interim results from a multicentre, open-label, randomised controlled phase 3 studyPippa G Corrie, Andrea Marshall, Janet A Dunn, et al.Pulmonary Circulation|October 16, 2023
Pulmonary hemodynamics and transplant-free survival in sarcoidosis-associated pulmonary hypertension: Results from an international registryShameek K Gayen, Robert P Baughman, Steven D Nathan, et al.Pageof 51